Dowdy DW - Search Results

1

Would pan-tuberculosis treatment regimens be cost-effective?

Kendall EA, Brigden G, Lienhardt C, Dowdy DW. Kendall EA, et al. Among authors: dowdy dw. Lancet Respir Med. 2018 Jul;6(7):486-488. doi: 10.1016/S2213-2600(18)30197-8. Epub 2018 May 31. Lancet Respir Med. 2018. PMID: 29859919 Free PMC article. Review. No abstract available.

2

Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.

Dowdy DW, O'Brien MA, Bishai D. Dowdy DW, et al. Int J Tuberc Lung Dis. 2008 Sep;12(9):1021-9. Int J Tuberc Lung Dis. 2008. PMID: 18713499

3

Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults.

Dowdy DW, Lourenço MC, Cavalcante SC, Saraceni V, King B, Golub JE, Bishai D, Durovni B, Chaisson RE, Dorman SE. Dowdy DW, et al. PLoS One. 2008;3(12):e4057. doi: 10.1371/journal.pone.0004057. Epub 2008 Dec 29. PLoS One. 2008. PMID: 19129940 Free PMC article.

4

Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis.

Dowdy DW, Steingart KR, Pai M. Dowdy DW, et al. PLoS Med. 2011 Aug;8(8):e1001074. doi: 10.1371/journal.pmed.1001074. Epub 2011 Aug 9. PLoS Med. 2011. PMID: 21857810 Free PMC article.

5

Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults.

Sun D, Dorman S, Shah M, Manabe YC, Moodley VM, Nicol MP, Dowdy DW. Sun D, et al. Among authors: dowdy dw. Int J Tuberc Lung Dis. 2013 Apr;17(4):552-8. doi: 10.5588/ijtld.12.0627. Int J Tuberc Lung Dis. 2013. PMID: 23485389 Free PMC article.

6

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action.

Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M. Wells WA, et al. Lancet Infect Dis. 2013 May;13(5):449-58. doi: 10.1016/S1473-3099(13)70025-2. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531393 Free PMC article. Review.

7

Cost-effectiveness of novel first-line treatment regimens for tuberculosis.

Owens JP, Fofana MO, Dowdy DW. Owens JP, et al. Among authors: dowdy dw. Int J Tuberc Lung Dis. 2013 May;17(5):590-6. doi: 10.5588/ijtld.12.0776. Int J Tuberc Lung Dis. 2013. PMID: 23575322 Free PMC article.

8

Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis.

Andrews JR, Lawn SD, Dowdy DW, Walensky RP. Andrews JR, et al. Among authors: dowdy dw. Clin Infect Dis. 2013 Oct;57(7):1021-6. doi: 10.1093/cid/cit412. Epub 2013 Jun 20. Clin Infect Dis. 2013. PMID: 23788239 Free PMC article.

9

Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States.

Choi HW, Miele K, Dowdy D, Shah M. Choi HW, et al. Int J Tuberc Lung Dis. 2013 Oct;17(10):1328-35. doi: 10.5588/ijtld.13.0095. Int J Tuberc Lung Dis. 2013. PMID: 24025386 Free PMC article.

10

Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?

Theron G, Peter J, Dowdy D, Langley I, Squire SB, Dheda K. Theron G, et al. Lancet Infect Dis. 2014 Jun;14(6):527-32. doi: 10.1016/S1473-3099(13)70360-8. Epub 2014 Jan 15. Lancet Infect Dis. 2014. PMID: 24438820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters